# Pegylated Interferon and Ribavirin in Hepatitis C Patients on Opioid Pharmacotherapy

> **NCT01120795** · PHASE4 · COMPLETED · sponsor: **Melbourne Health** · enrollment: 55 (actual)

## Conditions studied

- Chronic Hepatitis C

## Interventions

- **DRUG:** Pegylated interferon and ribavirin
- **DRUG:** Pegylated interferon and ribavirin

## Key facts

- **NCT ID:** NCT01120795
- **Lead sponsor:** Melbourne Health
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-02
- **Primary completion:** 2006-01
- **Final completion:** 2006-07
- **Target enrollment:** 55 (ACTUAL)
- **Last updated:** 2024-01-30

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01120795

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01120795, "Pegylated Interferon and Ribavirin in Hepatitis C Patients on Opioid Pharmacotherapy". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT01120795. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*